Open access · CC-BY
via OpenAlex
Progressive slowdown/prevention of cellular senescence by CD9-targeted delivery of rapamycin using lactose-wrapped calcium carbonate nanoparticles
Raj Kumar Thapa, Hanh Thuy Nguyen, Jee‐Heon Jeong, Jae Ryong Kim, Han‐Gon Choi, Chul Soon Yong, Jong Oh Kim
Scientific Reports · 2017 · ▲ 115 citations
Abstract
Abstract Cellular senescence(definition), a state of irreversible growth arrest and altered cell function, causes aging-related diseases. Hence, treatment modalities that could target aging cells would provide a robust therapeutic avenue. Herein, for the first time, we utilized CD9 receptors (overexpressed in senescent cells) for nanoparticle targeting in addition to the inherent β-galactosidase activity. In our study, CD9 monoclonal antibody-conjugated lactose-wrapped calcium carbonate nanoparticles loaded with mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (CD9-Lac/CaCO3/Rapa) were prepared for targeted rapamycin delivery to senescent cells. The nanoparticles exhibited an appropriate particle size (~130 nm) with high drug-loading capacity (~20%). In vitro drug release was enhanced in the presence of β-galactosidase suggesting potential cargo drug delivery to the senescent cells. Furthermore, CD9-Lac/CaCO3/Rapa exhibited high uptake and anti-senescence effects (reduced β-galactosidase and p53/p21/CD9/cyclin D1 expression, reduced population doubling time, enhanced cell proliferation and migration, and prevention of cell cycle arrest) in old human dermal fibroblasts. Importantly, CD9-Lac/CaCO3/Rapa significantly improved the proliferation capability of old cells as suggested by BrdU staining along with significant reductions in senescence-associated secretory phenotypes (IL-6 and IL-1β) (P < 0.05). Altogether, our findings suggest the potential applicability of CD9-Lac/CaCO3/Rapa in targeted treatment of senescence.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/srep43299
- Canonical
- link ↗
- Fetched
- 2026-09-03 MST
Cite this
APA
Thapa, R.K., Nguyen, H.T., Jeong, J., Kim, J.R., Choi, H., Yong, C.S., & Kim, J.O. (2017). Progressive slowdown/prevention of cellular senescence by CD9-targeted delivery of rapamycin using lactose-wrapped calcium carbonate nanoparticles. <em>Scientific Reports</em>. https://doi.org/10.1038/srep43299
Vancouver
Thapa RK, Nguyen HT, Jeong J, Kim JR, Choi H, Yong CS, et al. Progressive slowdown/prevention of cellular senescence by CD9-targeted delivery of rapamycin using lactose-wrapped calcium carbonate nanoparticles. Scientific Reports. 2017. doi:10.1038/srep43299.
BibTeX
@article{raj2017Progre,
title = {Progressive slowdown/prevention of cellular senescence by CD9-targeted delivery of rapamycin using lactose-wrapped calcium carbonate nanoparticles},
author = {Raj Kumar Thapa and Hanh Thuy Nguyen and Jee‐Heon Jeong and Jae Ryong Kim and Han‐Gon Choi and Chul Soon Yong and Jong Oh Kim},
journal = {Scientific Reports},
year = {2017},
doi = {10.1038/srep43299},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of the American College of Cardiology 2015
Open access · OA
Stem Cells Versus Senescence
Genetics and Molecular Research 2026
Open access · CC-BY
CELLULAR SENESCENCE: MOLECULAR MECHANISMS AND SENOLYTIC AND SENOMORPHIC STRATEGIES
Biomaterials Research 2023
Open access · CC-BY
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
Cell and Tissue Research 2007
Citation only
Telomeres, senescence, and hematopoietic stem cells
Springer eBooks 2007
Citation only
Senescence Signatures of Human Hematopoietic Stem Cells
Cell Death and Disease 2020
Open access · CC-BY